Bristol Myers Squibb Co. (BMY)
50.68
-0.99
(-1.92%)
USD |
NYSE |
Dec 09, 16:00
50.64
-0.04
(-0.08%)
After-Hours: 20:00
Bristol Myers Squibb EPS Diluted (Quarterly): 1.079 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.195B |
| Revenue (Quarterly) | 12.22B |
| Total Expenses (Quarterly) | 10.02B |
| Enterprise Value | 139.77B |
| Gross Profit Margin (Quarterly) | 66.00% |
| Profit Margin (Quarterly) | 17.96% |
| Earnings Yield | 5.84% |
| Operating Earnings Yield | 13.56% |
| Normalized Earnings Yield | 10.37 |